Improving Asthma Outcomes in an Urban Pediatric Population
Asthma

About this trial
This is an interventional treatment trial for Asthma focused on measuring asthma, emergency department, compliance, randomized clinical trial
Eligibility Criteria
Inclusion Criteria: age between 12 months and 17 years, inclusive; prior physician-diagnosed asthma; ≥1 other unscheduled visit for asthma in the previous 6 months and/or ≥1 hospitalization for asthma in the prior 12 months; a parent/guardian available for interview; residence in Washington, DC or a contiguous Maryland county; and requirement for ≥3 doses of nebulized albuterol in the ED at the time of enrollment. Exclusion Criteria: significant medical co-morbidities affecting the cardiorespiratory system; a visit to an allergist or a pulmonologist in the prior 6 months; ≥2 of the following: a current written asthma medical action plan, current use of >1 controller medication, or a scheduled visit for asthma care with their PCP in the prior two weeks; enrollment in another asthma research study; unavailability for telephone follow-up; or primary language other than English or Spanish.
Sites / Locations
- Children's National Medical Center